Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05482113 · ClinicalTrials.gov registry record · Phase 4
Measuring Opioid Use After Rotator Cuff Repair: Comparing the Effects of Standard vs. Extended-release Nerve Blocks
A Phase 4 study, sponsored by Carilion Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT05482113 is a Phase 4 study that has completed, run by Carilion Clinic. The registered enrollment target is 17 participants.
The verdict
NCT05482113, a Phase 4 study, has completed, sponsored by Carilion Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The investigators aim to determine if a longer acting nerve block, which is a local anesthetic, can help reduce opioid use after surgery in patients that are getting rotator cuff repair surgery. The investigators will also determine if the longer acting block can reduce the number of days that opioids are taken after surgery. Patients that schedule this type of surgery will be given information regarding the study and asked if they want to participate. If they do, they will be randomized to either receive the standard nerve block or the longer acting nerve block. Participants and physicians will not know which nerve block the participants are receiving. Participants will receive a standard pain medication prescription after surgery and will be asked to record pain scores, medications taken and satisfaction level every day in a journal for two weeks. Participants will be asked to bring in their medication bottles and pain journal to the 2-week follow up appointment. Participants' pain scores will be assessed in the office at the follow up appointment and study staff will conduct a pill count. Participants will return for a 6-week follow up appointment and pain scores will be assessed again at that time, and another pill count will be conducted. At this point the study will be complete.
Interventions
- DRUG Liposomal bupivacaine
- DRUG Bupivacaine Hcl 0.25% Inj
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2021-12-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05482113
The ClinicalTrials.gov registry entry for NCT05482113 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carilion Clinic, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT05482113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05482113 about?
NCT05482113 is a clinical study titled "Measuring Opioid Use After Rotator Cuff Repair: Comparing the Effects of Standard vs. Extended-release Nerve Blocks". The investigators aim to determine if a longer acting nerve block, which is a local anesthetic, can help reduce opioid use after surgery in patients that are getting rotator cuff repair surgery. The investigators will also determine if the longer acting block can reduce the number of days that opioi...
What is the current status of trial NCT05482113?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2021-03-09. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT05482113?
The interventions under investigation include: Liposomal bupivacaine (DRUG), Bupivacaine Hcl 0.25% Inj (DRUG).
Who is sponsoring clinical trial NCT05482113?
This trial is sponsored by Carilion Clinic, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.